GNRHR and polycystic ovary syndrome: An autoimmune PCOS model was successfully developed by immunizing rats with a synthetic peptide derived from the GnRHR-ECL2 sequence—identical to the epitope targeted by GnRHR autoantibodies in humans with PCOS [53].